KIT and leukemia: In contrast, a corresponding competition assay in vitro with standard cytokines (interleukin-3 [IL-3], IL-6, and stem cell factor [SCF]) demonstrated that disruption of Cxcr4 in c-Kit+ leukemia cells did not affect cell proliferation (FigureS3B).